Doctor Pankaj Jariwala

Doctor Pankaj Jariwala

Yashoda Hospital, Hyderabad (India)

Member of:

ACADEMIC POSITIONS ● Ex Assistant Professor of Cardiology [NIMS] ● Former Associate Editor of Indian Heart Journal. ● Associate editor of Journal of Indian College of Cardiology. ● Invited faculty in various National and International Cardiology Conferences. ● Has conducted more than 250 educational CMEs for medical students and General practitioners. AWARDS RECEIVED > Received Best prize for ‘ Call for Clinical Case ’ at EuroPCR 2009 . ● Received ‘ Data scope (Maquet) IABP scholarship for case presentation’ at TCT 2009 2010 , San Francisco,USA. FELLOWSHIP ● Interventional fellowship programme at Washington Hospital Centre, Washington, DC, USA in Interventional Cardiology in Oct 2007. ● Fellowship in Interventional Cardiology at Institut Cardiovasculaire Paris Sud [ICPS], Massy, Paris, France from Oct. 2009 to Oct. 2010 PUBLICATIONS Published more than 100 articles in various National and International journals.

Presentations Articles

The prevalence of risk factors and pattern of obstructive coronary artery disease in young indians (< 45 years) undergoing percutaneous coronary intervention: a gender-based multi-center study

Event: ESC Preventive Cardiology 2022

Topic: Cardiovascular Disease in Women

Session: Moderated posters session 2 - Population Science and Public Health

Access

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

Event: ESC Acute CardioVascular Care 2022

Topic: Acute Cardiac Care

Session: Best ePoster in Insights on classical and new aspects of acute care

Access

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

Event: ESC Acute CardioVascular Care 2022

Topic: Pharmacotherapy

Session: e-Posters session

Access

The ADDition of DAPAgliflozin to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory HFrEF

Event: ESC Congress 2021 - The Digital Experience

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Congress committee e-posters choice in heart failure

Access

Impact of DAPT duration on clinical outcome after stent implantation for coronary bifurcation lesions: Multicentre experience.

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiplatelet Drugs

Session: Pharmacology and pharmacotherapy e-posters

Access

Doctor Pankaj Jariwala

Biography

Contributor content

The prevalence of risk factors and pattern of obstructive coronary artery disease in young indians (< 45 years) undergoing percutaneous coronary intervention: a gender-based multi-center study

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

The ADDition of DAPAgliflozin to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory HFrEF

Impact of DAPT duration on clinical outcome after stent implantation for coronary bifurcation lesions: Multicentre experience.

ESC 365 is supported by